N. Kalupahana, Wenting Xin, A. Quignard‐Boulangé, D. Wasserman, N. Moustaid‐Moussa
{"title":"Overactivation of the adipose tissue renin angiotensin system contributes to insulin resistance in high‐fat diet‐induced obesity","authors":"N. Kalupahana, Wenting Xin, A. Quignard‐Boulangé, D. Wasserman, N. Moustaid‐Moussa","doi":"10.1096/fasebj.25.1_supplement.340.3","DOIUrl":null,"url":null,"abstract":"Although obesity is associated with overactivation of the adipose tissue renin angiotensin system (RAS), a causal link between the latter and metabolic complications of obesity is not established. Using mice overexpressing angiotensinogen (Agt) in adipose tissue via the aP2 promoter (aP2‐Agt mice), we investigated the effects of RAS overactivation or blockade on insulin resistance and glucose tolerance in high‐fat (HF) diet‐induced obesity. On a low‐fat diet, the aP2‐Agt mice were significantly more glucose‐intolerant than their wild type littermates. Interestingly, these differences were eliminated when both strains were fed high‐fat diets. Moreover, in both aP2‐Agt and control littermates, glucose intolerance was significantly improved by treatment with the angiotensin converting enzyme inhibitor, captopril. Further studies investigating potential mechanisms associated with these metabolic changes demonstrated that the insulin resistance of the aP2‐Agt mice was mainly due to reduced insulin‐stimulated glucose uptake by skeletal muscle and heart. Additional proteomic studies and cytokine assays showed that adipose Agt overproduction increases markers of adipose inflammation, lipogenesis and lipolysis. Thus, this study provides evidence for a causal link between adipose RAS overactivation and insulin resistance in obesity.","PeriodicalId":50455,"journal":{"name":"The FASEB Journal","volume":"25 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2011-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The FASEB Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1096/fasebj.25.1_supplement.340.3","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Although obesity is associated with overactivation of the adipose tissue renin angiotensin system (RAS), a causal link between the latter and metabolic complications of obesity is not established. Using mice overexpressing angiotensinogen (Agt) in adipose tissue via the aP2 promoter (aP2‐Agt mice), we investigated the effects of RAS overactivation or blockade on insulin resistance and glucose tolerance in high‐fat (HF) diet‐induced obesity. On a low‐fat diet, the aP2‐Agt mice were significantly more glucose‐intolerant than their wild type littermates. Interestingly, these differences were eliminated when both strains were fed high‐fat diets. Moreover, in both aP2‐Agt and control littermates, glucose intolerance was significantly improved by treatment with the angiotensin converting enzyme inhibitor, captopril. Further studies investigating potential mechanisms associated with these metabolic changes demonstrated that the insulin resistance of the aP2‐Agt mice was mainly due to reduced insulin‐stimulated glucose uptake by skeletal muscle and heart. Additional proteomic studies and cytokine assays showed that adipose Agt overproduction increases markers of adipose inflammation, lipogenesis and lipolysis. Thus, this study provides evidence for a causal link between adipose RAS overactivation and insulin resistance in obesity.
期刊介绍:
The FASEB Journal publishes international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While the journal strives to include research that cuts across the biological sciences, it also considers submissions that lie within one field, but may have implications for other fields as well. The journal seeks to publish basic and translational research, but also welcomes reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, The FASEB Journal also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section.